Exploring the anti-diabetic potential of Australian Aboriginal and Indian Ayurvedic plant extracts using cell-based assays

BMC Complementary and Alternative Medicine

Volumn 15, Issue 1, 2015, Pages

  Gulati, Vandana ^a   Gulati, Pankaj ^a   Harding, Ian H ^a   Palombo, Enzo A ^a  

^a SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Anti cancer; Anti diabetic; Anti oxidant; Plant extracts

Indexed keywords

ACACIA KEMPEANA EXTRACT; ACACIA TETRAGONOPHYLLA EXTRACT; ANTIDIABETIC AGENT; ANTINEOPLASTIC AGENT; AYURVEDIC DRUG; BEYERIA LESHNAULTII EXTRACT; CURCULIGO ORCHIOIDES EXTRACT; EUPHORBIA DRUMONDII EXTRACT; PLANT EXTRACT; PTEROCARPUS MARSUPIUM EXTRACT; SANTALUM SPICATUM EXTRACT; UNCLASSIFIED DRUG; VINCRISTINE; GLUCOSE;

3T3 CELL LINE; A549 CELL LINE; ADIPOGENESIS; ANTIDIABETIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; AUSTRALIAN ABORIGINE; CONTROLLED STUDY; DRUG CYTOTOXICITY; FEMALE; GLUCOSE TRANSPORT; HELA CELL LINE; HUMAN; HUMAN CELL; IC50; INDIAN; LIPID STORAGE; MEDICINAL PLANT; ADIPOCYTE; ANGIOSPERM; ANIMAL; AUSTRALIA; AYURVEDA; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; INDIA; LIPID METABOLISM; METABOLISM; MOUSE; PHYTOTHERAPY; TRADITIONAL MEDICINE;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ANGIOSPERMS; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; AUSTRALIA; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE; HELA CELLS; HUMANS; HYPOGLYCEMIC AGENTS; INDIA; LIPID METABOLISM; MEDICINE, AYURVEDIC; MEDICINE, TRADITIONAL; MICE; PHYTOTHERAPY; PLANT EXTRACTS;

EID: 84924341963     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/s12906-015-0524-8     Document Type: Article

References (53)

1. Baldea LAN, Martineau LC, Benhaddou-Andaloussi A, Arnason JT, Levy E, Haddad PS. Inhibition of intestinal glucose absorption by anti-diabetic medicinal plants derived from the James Bay Cree traditional pharmacopeia. J Ethnopharmacol. 2010;132(2):473-82.
2. Klein G, Kim J, Himmeldirk K, Cao Y, Chen X. Antidiabetes and anti-obesity activity of Lagerstroemia speciosa. Evidence Based Complementary and Alternative Medicine. 2007;4(4):401-8.
3. Heller S. Weight gain during insulin therapy in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2004;65(0):S23-7.
4. Chan CH, Ngoh GC, Yusoff R. A brief review on anti diabetic plants: Global distribution, active ingredients, extraction techniques and acting mechanisms. Pharmacognosy Reviews. 2012;6(11):22.
5. Tom Yates MJD, Schwarz PEH, Khunti K. Diabetes prevention: a call to action. Indian J Med Res. 2011;134(November):579-82.
6. Alonso-Castro AJ, Salazar-Olivo LA. The anti-diabetic properties of Guazuma ulmifolia are mediated by the stimulation of glucose uptake in normal and diabetic adipocytes without inducing adipogenesis. J Ethnopharmacol. 2008;118(2):252-6.
7. Yeo C-R, Yang C, Wong T-Y, Popovich DG. A quantified ginseng (panax ginseng C.A. Meyer) extract influences lipid acquisition and increases adiponectin expression in 3T3-L1 cells. Molecules. 2011;16(1):477-92.
8. Yeo CR, Lee SM, Popovich DG. Ginseng (Panax quinquefolius) reduces cell growth, lipid acquisition and increases adiponectin expression in 3 T3-L1 cells. Evidence-based Complementary and Alternative Medicine. 2011; Article ID 610625, 9 Pages.
9. Green H, Kehinde O. An established preadipose cell line and its differentiation in culture II. Factors affecting the adipose conversion. Cell. 1975;5(1):19-27.
10. Frost SC, Lane MD. Evidence for the involvement of vicinal sulfhydryl groups in insulin-activated hexose transport by 3T3-L1 adipocytes. J Biological Chemistry. 1985;260(5):2646-52.
11. Wu CH, Lin HT, Wu GJ, Wang SH, Tsai GJ. In vitro investigation of the hypoglycemic activity of yeasts using models of rat epididymal adipocyte and differentiated mouse 3T3-L1 adipocyte. Afr J Biotechnol. 2011;10(35):6773-83.
12. Habib SL, Rojna M. Diabetes and risk of cancer. ISRN Oncology. 2013;2013:16.
13. Cannata D, Fierz Y, Vijayakumar A, LeRoith D. Type 2 diabetes and cancer: what is the connection? Mount Sinai J Medicine. 2010;77(2):197-213.
14. Chowdhury TA. Diabetes and cancer. QJM: An Int J Medicine. 2010;103(12):905-15.
15. Aggarwal BB, Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol. 2006;71(10):1397-421.
16. Gulati V, Harding I, Palombo E. Enzyme inhibitory and antioxidant activities of traditional medicinal plants: potential application in the management of hyperglycemia. BMC Complement Altern Med. 2012;12(1):77.
17. Bhat M, Zinjarde SS, Bhargava SY, Kumar AR, Joshi BN. Antidiabetic Indian plants: a good source of potent amylase inhibitors. Evidence-based Complementary and Alternative Medicine. 2011; Article ID 810207, 6 pages.
18. Fischer D, Li Y, Ahlemeyer B, Krieglstein J, Kissel T. In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials. 2003;24(7):1121-31.
19. Huang C, Zhang Y, Gong Z, Sheng X, Li Z, Zhang W, et al. Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARγ pathway. Biochem Biophys Res Commun. 2006;348(2):571-8.
20. Kühn C, Arapogianni NE, Halabalaki M, Hempel J, Hunger N, Wober J, et al. Constituents from cistus salvifolius (cistaceae) activate peroxisome proliferator-activated receptor-γ but Not-δ and stimulate glucose uptake by adipocytes. Planta Medica-Natural Products and Medicinal Plant Res. 2011;77(4):346.
21. Wise LS, Green H. Participation of one isozyme of cytosolic glycerophosphate dehydrogenase in the adipose conversion of 3T3 cells. J Biological Chemistry. 1979;254(2):273-5.
22. Fang X-K, Gao J, Zhu D-N. Kaempferol and quercetin isolated from Euonymus alatus improve glucose uptake of 3T3-L1 cells without adipogenesis activity. Life Sci. 2008;82(11-12):615-22.
23. Roh C, Jung U. Screening of crude plant extracts with anti-obesity activity. Int J Mol Sci. 2012;13(2):1710-9.
24. Prabhakar PK, Doble M. Interaction of phytochemicals with hypoglycemic drugs on glucose uptake in L6 myotubes. Phytomedicine. 2011;18(4):285-91.
25. Loizzo MR, Saab AM, Tundis R, Menichini F, Bonesi M, Piccolo V, et al. In vitro inhibitory activities of plants used in Lebanon traditional medicine against angiotensin converting enzyme (ACE) and digestive enzymes related to diabetes. J Ethnopharmacol. 2008;119(1):109-16.
26. Itharat A, Houghton PJ, Eno-Amooquaye E, Burke PJ, Sampson JH, Raman A. In vitro cytotoxic activity of Thai medicinal plants used traditionally to treat cancer. J Ethnopharmacol. 2004;90(1):33-8.
27. Liu F, Kim J-k, Li Y, Liu X-q, Li J, Chen X. An extract of lagerstroemia speciosa L. Has insulin-like glucose uptake-stimulatory and adipocyte differentiation-inhibitory activities in 3T3-L1 cells. J Nutr. 2001;131(9):2242-7.
28. Ukiya M, Akihisa T, Tokuda H, Suzuki H, Mukainaka T, Ichiishi E, et al. Constituents of Compositae plants: III. Anti-tumor promoting effects and cytotoxic activity against human cancer cell lines of triterpene diols and triols from edible chrysanthemum flowers. Cancer Lett. 2002;177(1):7-12.
29. Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radical Biology and Medicine. 2001;30(11):1191-212.
30. Reddy L, Odhav B, Bhoola KD. Natural products for cancer prevention: a global perspective. Pharmacol Ther. 2003;99(1):1-13.
31. Dai J, Mumper RJ. Plant phenolics: extraction, analysis and their antioxidant and anticancer properties. Molecules. 2010;15(10):7313-52.
32. Cadenas E, Davies KJ. Mitochondrial free radical generation, oxidative stress, and aging. Free Radical Biology and Medicine. 2000;29(3):222-30.
33. Cameron AJ, Welborn TA, Zimmet PZ, Dunstan DW, Owen N, Salmon J, et al. Overweight and obesity in Australia: the 1999-2000 Australian diabetes, obesity and lifestyle study (AusDiab). Medical J Australia. 2003;178(9):427-32.
34. Simpson BS, Claudie DJ, Smith NM, McKinnon RA, Semple SJ. Learning from both sides: experiences and opportunities in the investigation of Australian aboriginal medicinal plants. J Pharm Pharm Sci. 2013;16(2):259-71.
35. Pandey G, Madhuri S. Some medicinal plants as natural anticancer agents. Pharmacognosy Rev. 2009;3(6):259.
36. Costa-Lotufo LV, Khan MTH, Ather A, Wilke DV, Jimenez PC, Pessoa C, et al. Studies of the anticancer potential of plants used in Bangladeshi folk medicine. J Ethnopharmacol. 2005;99(1):21-30.
37. Kim SH, Shin EJ, Kim ED, Bayaraa T, Frost SC, Hyun CK. Berberine activates GLUT1-mediated glucose uptake in 3T3-L1 adipocytes. Biological and Pharmaceutical Bulletin. 2007;30(11):2120-5.
38. Thareja S, Aggarwal S, Bhardwaj T, Kumar M. Protein tyrosine phosphatase 1B inhibitors: a molecular level legitimate approach for the management of diabetes mellitus. Med Res Rev. 2012;32(3):459-517.
39. Martín MÁ, Serrano ABG, Ramos S, Pulido MI, Bravo L, Goya L. Cocoa flavonoids up-regulate antioxidant enzyme activity via the ERK1/2 pathway to protect against oxidative stress-induced apoptosis in HepG2 cells. J Nutr Biochem. 2010;21(3):196-205.
40. Galleano M, Calabro V, Prince PD, Litterio MC, Piotrkowski B, Vazquez-Prieto MA, et al. Flavonoids and metabolic syndrome. Ann N Y Acad Sci. 2012;1259(1):87-94.
41. Klover PJ, Mooney RA. Hepatocytes: critical for glucose homeostasis. Int J Biochem Cell Biol. 2004;36(5):753-8.
42. Cordero-Herrera I, Martín MA, Bravo L, Goya L, Ramos S. Cocoa flavonoids improve insulin signalling and modulate glucose production via AKT and AMPK in HepG2 cells. Mol Nutr Food Res. 2013;57(6):974-85.
43. Ismail WIW, King JA, Anwar K, Pillay TS. Indinavir and nelfinavir inhibit proximal insulin receptor signaling and salicylate abrogates inhibition: Potential role of the NFkappa B pathway. J Cell Biochem. 2013;114(8):1729-37.
44. Ismail WIW, Abu MN, Salleh MAM, Radzman NHM, Yusof RM, Hassan HF. Insulin sensitivity enhancement of the mixture of Tinospora crispa and gelam (Melaleuca cajuputi) honey and its antiproliferative activity on hepatocellular carcinoma, HepG2: A preliminary study. J Medical Res Dev. 2013;2(3):48-54.
45. Avram MM, Avram AS, James WD. Subcutaneous fat in normal and diseased states: 3. Adipogenesis: from stem cell to fat cell. J Am Acad Dermatol. 2007;56(3):472-92.
46. Nagatomo A, Nishida N, Matsuura Y, Shibata N. Rosehip extract inhibits lipid accumulation in white adipose tissue by suppressing the expression of peroxisome proliferator-activated receptor gamma. Preventive Nutrition and Food Science. 2013;18(2):85.
47. Rayalam S, Della-Fera MA, Baile CA. Phytochemicals and regulation of the adipocyte life cycle. J Nutr Biochem. 2008;19(11):717-26.
48. Rimando AM, Nagmani R, Feller DR, Yokoyama W. Pterostilbene, a New agonist for the peroxisome proliferator-activated receptor α-isoform, lowers plasma lipoproteins and cholesterol in hypercholesterolemic hamsters. J Agric Food Chem. 2005;53(9):3403-7.
49. Popovich DG, Li L, Zhang W. Bitter melon (Momordica charantia) triterpenoid extract reduces preadipocyte viability, lipid accumulation and adiponectin expression in 3T3-L1 cells. Food Chem Toxicol. 2010;48(6):1619-26.
50. Deutschländer M, Lall N, Van de Venter M, Hussein AA. Hypoglycemic evaluation of a new triterpene and other compounds isolated from Euclea undulata Thunb. var. myrtina (Ebenaceae) root bark. J Ethnopharmacol. 2011;133(3):1091-5.
51. Muthusamy VS, Anand S, Sangeetha KN, Sujatha S, Arun B, Lakshmi BS. Tannins present in Cichorium intybus enhance glucose uptake and inhibit adipogenesis in 3T3-L1 adipocytes through PTP1B inhibition. Chem Biol Interact. 2008;174(1):69-78.
52. Leopoldini M, Russo N, Toscano M. The molecular basis of working mechanism of natural polyphenolic antioxidants. Food Chem. 2011;125(2):288-306.
53. Čipák L, Rauko P, Miadoková E, Čipáková I, Novotný L. Effects of flavonoids on cisplatin-induced apoptosis of HL-60 and L1210 leukemia cells. Leuk Res. 2003;27(1):65-72.